Minerva Neurosciences $32.7 Million IPO

Boston – Cooley advised the underwriters on Minerva Neurosciences' $32.7 million IPO. Minerva is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company now trades on the Nasdaq Global Stock Market under the symbol "NERV."

Jefferies acted as sole book-running manager for the offering and Baird and JMP Securities acted as co-managers.

Thus far in 2014, Cooley has advised on 65 completed public offerings, including 32 completed IPOs.

Related Contacts
Nicole Brookshire Partner, Boston
Darren DeStefano Partner, Reston
Charlie Kim Partner, San Diego
Kristin VanderPas Partner, San Francisco
Natasha Leskovsek Partner, Washington, DC
Wendy Goldstein Partner, New York
Phil Mitchell Partner, New York
Bill Christiansen Partner, Seattle
Renee Deming Retired Partner, Palo Alto
Susan Cooper Philpot Retired Partner, San Francisco